AUG 29, 2017 3:38 PM PDT

How Belly Fat Increases Risk for Cancer

WRITTEN BY: Xuan Pham

Image credit: Pixabay.com

It’s no secret that obesity is a risk factor for several health conditions, including cancer. But specific to cancer, researchers knew of the link, but they didn’t know exactly how fat promotes cancer growth. Now, researchers from Michigan State University say they a specific type of belly fat is responsible for turning healthy cells into cancerous ones.

"While there have been several advances in treating cancer and improving the quality of life of patients, the number of new cases continues to surge," said Jamie Bernard, lead author and an assistant professor in pharmacology and toxicology. "It's important to understand the cause so we can do a better job at reducing the number of cancer cases using dietary modifications or therapeutic interventions."

Bernard and colleagues investigated the link between body fat and cancer in a mouse model of obesity. These mice were fed a high-fat diet to simulate obesity seen in humans. In these mice, as in humans, the team could discern two layers of fat: the top layer, also known as subcutaneous fat that’s directly under the skin; and an internal layer, also known as visceral fat or visceral fat. Of the two types of fat, belly fat is by far more dangerous to our health. This type of fat extends deep inside the body and envelopes vital organs like the heart, stomach, liver, and pancreas. The proximity and abundance of the fat increases the conversion of fat into cholesterol that can leech into the bloodstream and cause plaque buildups in the arteries. This is why belly fat is associated with high risk for coronary artery disease and cardiovascular disease. Belly fat also contributes to a multitude of other health problems, such as Type 2 diabetes and cancer.

In the obese mice, Bernard’s team found visceral fat cells produced higher amounts of the fibroblast growth factor-2 (FGF2) protein, as compared to fat cells in the subcutaneous layer. This protein seemed to promote the conversion of non-cancerous to cancerous cells. Those cells that were already vulnerable to the protein seemed most susceptible turning into tumor cells.

Bernard then sampled human visceral fat tissues taken from women who were undergoing hysterectomies. They found that when the fat had higher amounts of FGF-2 secretions, the cells were more likely to turn cancerous when injected into mice. "This would indicate that fat from both mice and humans can make a non-tumorigenic cell malignantly transform into a tumorigenic cell," Bernard said.

These results concur with previous studies, which argued that the location of the fat matters in cancer development. In one such study, researchers found that people who had an increase of 11 centimeters at the waist are 13 percent more likely to get obesity-related cancers.

"Our study suggests that body mass index, or BMI, may not be the best indicator," Bernard said. "It's abdominal obesity, and even more specifically, levels of a protein called fibroblast growth factor-2 that may be a better indicator of the risk of cells becoming cancerous."

Of course belly fat is not the only contributing factor to obesity-related cancers. Moreover, having belly fat does not mean a person will, in fact, develop cancer. "There's always an element of chance in whether a person will get cancer or not," said Bernard. "But by making smarter choices when it comes to diet and exercise and avoiding harmful habits like smoking, people can always help skew the odds in their favor."

Additional sources: Michigan State University

About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
SEP 12, 2020
Cancer
Treating cancer with the botanical andrographis
SEP 12, 2020
Treating cancer with the botanical andrographis
A study from City of Hope published in the journal Carcinogenesis reports that the use of the natural botanical And ...
SEP 13, 2020
Cancer
Should we be treating kidney cancer differently?
SEP 13, 2020
Should we be treating kidney cancer differently?
New research published in the journal Clinical Cancer Research is questioning how we treat kidney tumors. According ...
SEP 29, 2020
Cancer
Gut microbiome influences oral therapy for prostate cancer treatment
SEP 29, 2020
Gut microbiome influences oral therapy for prostate cancer treatment
Research from a team of scientists at Lawson Health Research Institute and Western University suggests that bacteria in ...
OCT 20, 2020
Clinical & Molecular DX
Non-coding RNA As A Barometer For Liver Health
OCT 20, 2020
Non-coding RNA As A Barometer For Liver Health
October is liver cancer awareness month — a month dedicated to educating people about the risk factors and prevent ...
OCT 22, 2020
Cancer
Cancer cells don't like crowded spaces
OCT 22, 2020
Cancer cells don't like crowded spaces
Researchers collaborating from St. Anna Children's Cancer Research Institute Vienna, King's College London, Inst ...
OCT 25, 2020
Cell & Molecular Biology
Revealing More About the Genetics of Ewing Sarcoma
OCT 25, 2020
Revealing More About the Genetics of Ewing Sarcoma
Ewing sarcoma is a rare kind of cancer that tends to impact young people and occurs in bones or the tissue around them. ...
Loading Comments...